These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 30367738)

  • 21. Modulation of rat brain endogenous dopamine metabolism by new inhibitors of catechol O-methyltransferase.
    Törnwall M; Tuomainen P; Männistö PT
    Eur J Pharmacol; 1993 Aug; 239(1-3):39-45. PubMed ID: 8223912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro metabolism of tolcapone to reactive intermediates: relevance to tolcapone liver toxicity.
    Smith KS; Smith PL; Heady TN; Trugman JM; Harman WD; Macdonald TL
    Chem Res Toxicol; 2003 Feb; 16(2):123-8. PubMed ID: 12588182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of myo-inositol tris pyrophosphate (ITPP) in equine following an administration of ITPP.
    Lam G; Zhao S; Sandhu J; Yi R; Loganathan D; Morrissey B
    Drug Test Anal; 2014 Mar; 6(3):268-76. PubMed ID: 23733541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensitive liquid chromatographic/tandem mass spectrometric method for the determination of beclomethasone dipropionate and its metabolites in equine plasma and urine.
    Guan F; Uboh C; Soma L; Hess A; Luo Y; Tsang DS
    J Mass Spectrom; 2003 Aug; 38(8):823-38. PubMed ID: 12938103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liquid chromatography electrospray ionization tandem mass spectrometry for the detection of mesocarb abuse in horse doping.
    Appolonova SA; Baranov PA; Mesonzhnik NV; Brazhnikova DO; Rodchenkov GM
    Drug Test Anal; 2011 Oct; 3(10):717-23. PubMed ID: 21964865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salvianolic acid B as a substrate and weak catechol-O-methyltransferase inhibitor in rats.
    Qi Q; Cao L; Li F; Wang H; Liu H; Hao H; Hao K
    Xenobiotica; 2015; 45(9):820-7. PubMed ID: 25869243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Doping control analysis of four JWH-250 metabolites in equine urine by liquid chromatography-tandem mass spectrometry.
    You Y; Proctor RM; Vasilko ED; Robinson MA
    Drug Test Anal; 2019 May; 11(5):649-658. PubMed ID: 30423218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain catechol-O-methyltransferase (COMT) inhibition by tolcapone counteracts recognition memory deficits in normal and chronic phencyclidine-treated rats and in COMT-Val transgenic mice.
    Detrait ER; Carr GV; Weinberger DR; Lamberty Y
    Behav Pharmacol; 2016 Aug; 27(5):415-21. PubMed ID: 26919286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioanalytical chromatographic methods for the determination of catechol-O-methyltransferase inhibitors in rodents and human samples: a review.
    Gonçalves D; Alves G; Soares-da-Silva P; Falcão A
    Anal Chim Acta; 2012 Jan; 710():17-32. PubMed ID: 22123108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of tolcapone, a catechol-O-methyltransferase inhibitor, on striatal dopaminergic transmission during blockade of dopamine uptake.
    Budygin EA; Gainetdinov RR; Kilpatrick MR; Rayevsky KS; Männistö PT; Wightman RM
    Eur J Pharmacol; 1999 Apr; 370(2):125-31. PubMed ID: 10323260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. General properties and clinical possibilities of new selective inhibitors of catechol O-methyltransferase.
    Kaakkola S; Gordin A; Männistö PT
    Gen Pharmacol; 1994 Sep; 25(5):813-24. PubMed ID: 7835624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a method for the detection and confirmation of the alpha-2 agonist amitraz and its major metabolite in horse urine.
    Lehner AF; Hughes CG; Karpiesiuk W; Harkins JD; Dirikolu L; Bosken J; Camargo F; Boyles J; Troppmann A; Woods WE; Tobin T
    J Anal Toxicol; 2004 Oct; 28(7):553-62. PubMed ID: 15516314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of the Catechol-O-Methyltransferase Inhibitors Tolcapone and Entacapone on Fatty Acid Metabolism in HepaRG Cells.
    Grünig D; Felser A; Duthaler U; Bouitbir J; Krähenbühl S
    Toxicol Sci; 2018 Aug; 164(2):477-488. PubMed ID: 29688484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Doping control analysis of 46 polar drugs in horse plasma and urine using a 'dilute-and-shoot' ultra high performance liquid chromatography-high resolution mass spectrometry approach.
    Kwok WH; Choi TLS; Kwok KY; Chan GHM; Wong JKY; Wan TSM
    J Chromatogr A; 2016 Jun; 1451():41-49. PubMed ID: 27180888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of tolcapone, a catechol-O-methyltransferase inhibitor, on motor symptoms and pharmacokinetics of levodopa in patients with Parkinson's disease.
    Yamamoto M; Yokochi M; Kuno S; Hattori Y; Tsukamoto Y; Narabayashi H; Tohgi H; Mizuno Y; Kowa H; Yanagisawa N; Kanazawa I
    J Neural Transm (Vienna); 1997; 104(2-3):229-36. PubMed ID: 9203084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of tramadol and its main metabolites in horse plasma by high-performance liquid chromatography/fluorescence and liquid chromatography/electrospray ionization tandem mass spectrometry techniques.
    De Leo M; Giorgi M; Saccomanni G; Manera C; Braca A
    Rapid Commun Mass Spectrom; 2009 Jan; 23(2):228-36. PubMed ID: 19072864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tolcapone, an inhibitor of catechol O-methyltransferase, counteracts memory deficits caused by bilateral cholinotoxin lesions of the basal nuclei of Meynert.
    Khromova I; Rauhala P; Zolotov N; Männistö PT
    Neuroreport; 1995 May; 6(8):1219-22. PubMed ID: 7662912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of monoamine oxidase and catechol-O-methyltransferase inhibition on dopamine turnover: a PET study with 6-[18F]L-DOPA.
    Doudet DJ; Chan GL; Holden JE; Pate BD; Morrison KS; Calne DB; Ruth TJ
    Eur J Pharmacol; 1997 Sep; 334(1):31-8. PubMed ID: 9346324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Minor effect of tolcapone, a catechol-O-methyltransferase inhibitor, on extracellular dopamine levels modified by amphetamine or pargyline: a microdialysis study in anaesthetized rats.
    Tuomainen P; Törnwall M; Männistö PT
    Pharmacol Toxicol; 1996 Jun; 78(6):392-6. PubMed ID: 8829199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The COMT inhibitor tolcapone potentiates the anticataleptic effect of Madopar in MPP(+)-lesioned mice.
    Himori N; Mishima K
    Experientia; 1994 Oct; 50(10):939-42. PubMed ID: 7957769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.